Callicarpa Macrophylla

Callicarpa macrophylla  Vahl.

1. Taxonomic, Nomenclature & Therapeutic Summary Table

Botanical Attribute Pharmacognostic & Therapeutic Specification
Synonym C. incana Roxb.
Family Verbenaceae.
Habitat Sub-Himalayan tracts, from Hazara eastwards to Assam, up to 1,500 m.
English Perfumed Cherry.
Ayurvedic Priyangu, Priyangukaa, Priyaka, Gandhphali, Gandhpriyangu, Phalini, Vanitaa, Kaantaa, Kaantaahvaa, Shyamaa, Anganaapriya.
Unani Habb-ul-Mihlb (Prunus mahaleb Linn., Rosaceae).
Siddha / Tamil Gnazhal, Chokkala. (Fruits of Aglaia roxburghiana Miq. are used as Priyangu.)
Action Leaves—applied hot in rheumatic pains. Smoked to relieve headache. Seed—paste used in stomatitis. Wood—paste used in mouth and tongue sores. Seeds and roots—employed as stomachic. Bark—used in rheumatism and diseases of genitourinary tract. The Ayurvedic Pharmacopoeia of India indicated the use of the fruit in emesis and giddiness.
Dosage Dried inflorescences powder—1–3 g (API Vol. II); fruit powder—1–2 g. (API Vol. IV.)
Taxonomic Cohort Genus Callicarpa (1 documented species); Family Verbenaceae (27 documented species).

2. Classical Nomenclature, Taxonomy & Biogeographical Context

Callicarpa macrophylla (taxonomically cited with authority Vahl.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Verbenaceae (primary family classification: Verbenaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy C. incana Roxb, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Sub-Himalayan tracts, from Hazara eastwards to Assam, up to 1,500 m.

Across classical and vernacular Indian systems of medicine, Callicarpa macrophylla is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Perfumed Cherry; in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Priyangu, Priyangukaa, Priyaka, Gandhphali, Gandhpriyangu, Phalini, Vanitaa, Kaantaa, Kaantaahvaa, Shyamaa, Anganaapriya; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Habb-ul-Mihlb (Prunus mahaleb Linn., Rosaceae); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Gnazhal, Chokkala. (Fruits of Aglaia roxburghiana Miq. are used as Priyangu.). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.

3. Therapeutic Actions, Phytochemistry & Pharmacological Profile

In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Callicarpa macrophylla are: Leaves—applied hot in rheumatic pains. Smoked to relieve headache. Seed—paste used in stomatitis. Wood—paste used in mouth and tongue sores. Seeds and roots—employed as stomachic. Bark—used in rheumatism and diseases of genitourinary tract. The Ayurvedic Pharmacopoeia of India indicated the use of the fruit in emesis and giddiness. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.

Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Callicarpa macrophylla establish the following evidence base: The seeds and leaves contain calliterpenone and its monoacetate; the former also contain fatty acids, betasitosterol and its beta-D-glucoside.

In specialized pharmacognostic classifications, Callicarpa macrophylla is also recognized among important classical herbs with divergent regional plant sources across North and South Indian formularies; and represented by authenticated macro-photographic crude drug specimens in institutional pharmacognostic collections.

image1

Figure 1: Authenticated crude herb specimen — Callicarpa macrophylla dried flower.

image3

Botanical Reference 1: Callicarpa macrophylla — Botanical specimen

image4

Botanical Reference 2: Callicarpa macrophylla — Botanical specimen

image4

Botanical Reference 3: Callicarpa macrophylla — Wikimedia Commons reference

4. Comparative Genus & Family Pharmacognosy

Within Indian medicinal flora, Callicarpa macrophylla stands as a distinct representative of the genus Callicarpa. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.

At the family level, Verbenaceae encompasses 27 documented medicinal species (1.49% of the 1,814-species flora). Other representative medicinal members of Verbenaceae include: Avicennia officinalis (Tuvara), Clerodendrum indicum (Vaamana-haati), Clerodendrum inerme (Putigandhaa), Clerodendrum infortunatum (Bhaandira), Duranta plumieri (Durantaa). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

image2

Figure 2: Quantitative documentation profile across all 27 medicinal species of family Verbenaceae.

5. Pharmacopoeial Standards, Posology & Reference Framework

For clinical and traditional dispensing, the standardized posology and crude herb dosage for Callicarpa macrophylla are prescribed as follows: Dried inflorescences powder—1–3 g (API Vol. II); fruit powder—1–2 g. (API Vol. IV.). Crude drug dosages are calibrated against The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and the Standard Nomenclature of Ayurvedic Medicinal Plants published by the Central Council for Research in Ayurveda and Siddha (CCRAS). Classical and modern pharmacognostic synchronization for Callicarpa macrophylla integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.

Scroll to Top